Edina, MN – June 5, 2025 – Octin Health, Inc, a medical device company focused on de-risking aortic surgery, announced today that it has been selected to join the MedTech Innovator 2025 Accelerator Cohort. Octin Health is one of only 65 companies—representing the top 4% of nearly 1,500 global applicants—chosen for this year’s program.

MedTech Innovator (MTI) is the world’s largest accelerator for medical technology startups. The highly competitive four-month program provides participants with world-class mentorship, strategic guidance, and access to a robust network of investors, providers, payers, manufacturers, and industry experts.

“We are honored to join this year’s MedTech Innovator cohort,” said Meghana Helder, CEO of Octin Health. “This opportunity gives us a powerful platform to validate our technology, build key partnerships, and accelerate our path to market.”

Throughout the program, cohort companies will present at major industry events including The MedTech Conference powered by AdvaMed (October 5–8 in San Diego) and/or the MedTech Strategist Innovation Summit (November 19–21 in San Diego), where they will compete for a share of $800,000 in non-dilutive funding.